380 related articles for article (PubMed ID: 34639115)
1. Lysophosphatidic Acid Mediates Imiquimod-Induced Psoriasis-like Symptoms by Promoting Keratinocyte Proliferation through LPAR1/ROCK2/PI3K/AKT Signaling Pathway.
Kim D; Kim HJ; Baek JO; Roh JY; Jun HS
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639115
[TBL] [Abstract][Full Text] [Related]
2. LPA/LPAR1 signaling induces PGAM1 expression via AKT/mTOR/HIF-1α pathway and increases aerobic glycolysis, contributing to keratinocyte proliferation.
Kim D; Khin PP; Lim OK; Jun HS
Life Sci; 2022 Dec; 311(Pt B):121201. PubMed ID: 36400203
[TBL] [Abstract][Full Text] [Related]
3. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic Acid Induces Ligamentum Flavum Hypertrophy Through the LPAR1/Akt Pathway.
Zhou T; Du L; Chen C; Han C; Li X; Qin A; Zhao C; Zhang K; Zhao J
Cell Physiol Biochem; 2018; 45(4):1472-1486. PubMed ID: 29466791
[TBL] [Abstract][Full Text] [Related]
5. Cornulin Is Induced in Psoriasis Lesions and Promotes Keratinocyte Proliferation via Phosphoinositide 3-Kinase/Akt Pathways.
Li C; Xiao L; Jia J; Li F; Wang X; Duan Q; Jing H; Yang P; Chen C; Wang Q; Liu J; Shao Y; Wang N; Zheng Y
J Invest Dermatol; 2019 Jan; 139(1):71-80. PubMed ID: 30009832
[TBL] [Abstract][Full Text] [Related]
6. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
[TBL] [Abstract][Full Text] [Related]
7. Sortilin regulates keratinocyte proliferation and apoptosis through the PI3K-AKT signaling pathway.
Zhang R; Wang YH; Shi X; Ji J; Zhan FQ; Leng H
Life Sci; 2021 Aug; 278():119630. PubMed ID: 34004257
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
Park E; Kim D; Lee SM; Jun HS
Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic Acid Receptor 5 Contributes to Imiquimod-Induced Psoriasis-Like Lesions through NLRP3 Inflammasome Activation in Macrophages.
Gaire BP; Lee CH; Kim W; Sapkota A; Lee DY; Choi JW
Cells; 2020 Jul; 9(8):. PubMed ID: 32707926
[TBL] [Abstract][Full Text] [Related]
10. Lucidone Promotes the Cutaneous Wound Healing Process via Activation of the PI
Yang HL; Tsai YC; Korivi M; Chang CT; Hseu YC
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):151-168. PubMed ID: 27816443
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ChREBP ubiquitination via the ROS/Akt-dependent downregulation of Smurf2 contributes to lysophosphatidic acid-induced fibrosis in renal mesangial cells.
Kim D; Nam GY; Seo E; Jun HS
J Biomed Sci; 2022 May; 29(1):31. PubMed ID: 35538534
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MEG3 suppresses PI3K/AKT/mTOR signalling pathway to enhance autophagy and inhibit inflammation in TNF-α-treated keratinocytes and psoriatic mice.
Tang ZL; Zhang K; Lv SC; Xu GW; Zhang JF; Jia HY
Cytokine; 2021 Dec; 148():155657. PubMed ID: 34425525
[TBL] [Abstract][Full Text] [Related]
13. Taxifolin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like mouse model via regulating cytoplasmic phospholipase A2 and PPAR-γ pathway.
Di T; Zhai C; Zhao J; Wang Y; Chen Z; Li P
Int Immunopharmacol; 2021 Oct; 99():107900. PubMed ID: 34233233
[TBL] [Abstract][Full Text] [Related]
14. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy.
Lee GH; Cheon J; Kim D; Jun HS
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142408
[TBL] [Abstract][Full Text] [Related]
16. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model.
Wu S; Zhao M; Sun Y; Xie M; Le K; Xu M; Huang C
Life Sci; 2020 Jan; 241():117115. PubMed ID: 31790685
[TBL] [Abstract][Full Text] [Related]
17. Tranexamic acid improves psoriasis-like skin inflammation: Evidence from in vivo and in vitro studies.
Hseu JH; Chan CI; Vadivalagan C; Chen SJ; Yen HR; Hseu YC; Yang HL; Wu PY
Biomed Pharmacother; 2023 Oct; 166():115307. PubMed ID: 37573659
[TBL] [Abstract][Full Text] [Related]
18. LPA Induces Keratinocyte Differentiation and Promotes Skin Barrier Function through the LPAR1/LPAR5-RHO-ROCK-SRF Axis.
Sumitomo A; Siriwach R; Thumkeo D; Ito K; Nakagawa R; Tanaka N; Tanabe K; Watanabe A; Kishibe M; Ishida-Yamamoto A; Honda T; Kabashima K; Aoki J; Narumiya S
J Invest Dermatol; 2019 May; 139(5):1010-1022. PubMed ID: 30447238
[TBL] [Abstract][Full Text] [Related]
19. PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis.
Mercurio L; Morelli M; Scarponi C; Scaglione GL; Pallotta S; Albanesi C; Madonna S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685616
[TBL] [Abstract][Full Text] [Related]
20. Sinomenine Suppressed Keratinocyte Proliferation and Imiquimod-Induced Psoriasis-Like Dermatitis by Regulating lncRNA XIST.
Xiang S; Wu X; Xiang Y
Skin Pharmacol Physiol; 2022; 35(6):328-342. PubMed ID: 35960313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
